Zevra Therapeutics, Inc. ( ZVRA) - Stock Earnings
ZVRA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -544000 USD | 26.1 million USD |
| 2025Q4 | 12.2 million USD | 34.1 million USD |
| 2026Q1 | 37.9 million USD | 36.2 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ZVRA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -46.0 million USD | 27.5 million USD |
| 2024 | -105.5 million USD | 23.6 million USD |
| 2025 | 83.2 million USD | 106.5 million USD |
| 2026 Est. | — | — |
ZVRA
Price: $12.62
52 week price:
Earnings Per Share: 2.01 USD
P/E Ratio: 5.37
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 647.9 million